MEDICAL RESOURCES

Evobrutinib 
BTK inhibitor

Status

Evobrutinib is a BTK inhibitor currently under investigation in clinical trials for the treatment of multiple sclerosis.

Action SVG
Action SVG
Action SVG
eMedI Chat
Close
After your vist, Please answer a few questions to help us improve?
Survey
Please click on icon to provide survey...